| EPD472 | Prevalence and co-occurrence of symptoms of mental disorders and substance use among people with HIV aged >40 years in low- and middle-income countries in the Sentinel Research Network of IeDEA | E-poster | Living with HIV and co-infections and/or co-morbidities |
| EPD473 | Household decision-making power and symptoms of depression, anxiety and PTSD among people with HIV in Cameroon | E-poster | Living with HIV and co-infections and/or co-morbidities |
| EPD474 | High risk behaviour and syphilis co-infection among people living with HIV in Mumbai, India ' Need for comprehensive interventions | E-poster | Living with HIV and co-infections and/or co-morbidities |
| EPD475 | Associations of mental health disorders and substance use with detectable viral load by sex among older adults with HIV from low- and middle-income countries, the Sentinel Research Network of IeDEA | E-poster | Living with HIV and co-infections and/or co-morbidities |
| OAD0405 | DOTS PLUS: a promising approach to increasing adherence to tuberculosis, drug resistant tuberculosis and antiretroviral HIV treatment in Mozambique | Oral abstract session with live Q&A | Living with HIV and co-infections and/or co-morbidities |
| OAD0703 | Mental health services utilization among young Black gay, bisexual, and other men who have sex with men living with HIV | Oral abstract session with live Q&A | Living with HIV and co-infections and/or co-morbidities |
| EPB179 | Initiating long-acting cabotegravir and rilpivirine in a real-world setting ' clinical characteristics and switch reasons from people living with HIV (PLHIV) and health care provider perspective in the German CARLOS cohort | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |
| EPB180 | Long-acting cabotegravir+rilpivirine in older adults: pooled Phase 3 Week 96 | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |
| EPB181 | 'Give it a Shot': best practices from HCPs for administering long-acting cabotegravir+rilpivirine | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |
| EPB182 | Long-acting cabotegravir+rilpivirine injection site reactions: pooled Week 96 results | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |